EPAS1 and breast carcinoma: A detailed global assessment of HIF1α and HIF2α binding sites in MCF7 breast cancer cells, for instance, revealed that many of these sites bound HIF1α and HIF2α equally well, while there were only very few sites that bound HIF2α exclusively [62].